AIMOVIG

novartis pharmaceuticals canada inc🇨🇦 Health Canada

Approval Id: 47766d7be65391fe
Drug Approval Canada Name: AIMOVIG
Product Name: AIMOVIG
Status: Marketed
Status Date: 2019-05-22
Original Market Date: 2019-05-22
Din: 02487306
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Schedule D , Prescription
Ahfs: 28:32.12
Atc Original: N02CD01 ERENUMAB
Atc Name: n 02 cd 01
Aig Number: 0160530002
Company Name: novartis pharmaceuticals canada inc
Company Address: 100, 700 Rue Saint-Hubert, Montreal, Quebec, Canada, H2Y 0C1

ERENUMAB

140 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

47766d7be65391fe

Type

Standard